Holders — by stockHoldings — by fund
JW Asset Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001549738
$319.9M
disclosed book value
21
positions
72.2%
largest position share
Positions, as of 2026-06-30
top 21 of 21 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ESTABLISHMENT LABS HLDGS INC | 2.7M | $231.1M | 72.2% |
| 2 | SNDKSANDISK CORP | 7,810 | $17.8M | 5.6% |
| 3 | COCOVITA COCO CO INC | 218,621 | $14.5M | 4.5% |
| 4 | CATALYST PHARMACEUTICALS INC | 388,392 | $12.2M | 3.8% |
| 5 | MUMICRON TECHNOLOGY INC | 7,000 | $8.1M | 2.5% |
| 6 | IREN LIMITED | 144,650 | $6.6M | 2.1% |
| 7 | IDRIDAHO STRATEGIC RESOURCES | 141,197 | $4.6M | 1.4% |
| 8 | RLRALPH LAUREN CORP | 10,000 | $4.0M | 1.3% |
| 9 | CAVACAVA GROUP INC | 50,000 | $3.9M | 1.2% |
| 10 | NVDANVIDIA CORPORATION | 15,250 | $3.1M | 1% |
| 11 | ON HLDG AG | 72,950 | $2.6M | 0.8% |
| 12 | FIVEFIVE BELOW INC | 10,000 | $1.8M | 0.6% |
| 13 | TVTXTRAVERE THERAPEUTICS INC | 30,000 | $1.7M | 0.5% |
| 14 | HRTXHERON THERAPEUTICS INC | 3.8M | $1.6M | 0.5% |
| 15 | DELLDELL TECHNOLOGIES INC | 3,500 | $1.5M | 0.5% |
| 16 | LGNDLIGAND PHARMACEUTICALS INC | 4,000 | $1.3M | 0.4% |
| 17 | MRVLMARVELL TECHNOLOGY INC | 3,200 | $953,248 | 0.3% |
| 18 | TRULIEVE CANNABIS CORP | 83,869 | $824,432 | 0.3% |
| 19 | LQDALIQUIDIA CORPORATION | 10,176 | $811,332 | 0.3% |
| 20 | MSOSADVISORSHARES TR | 155,000 | $787,400 | 0.2% |
| 21 | HITIHIGH TIDE INC | 96,643 | $220,346 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.